Truth, Inspiration, Hope.

NEWS

Beijing: Heavy Rains Thwart Plan to Produce More Coal for Resolving Power Crisis
China is reeling under a significant power crisis. There is a shortage of coal to produce electricity...
18 Former NBA Players Charged with Defrauding Health and Welfare Benefit Plan
On Thursday, Oct. 7, Federal prosecutors announced that 18 former National Basketball Association (NBA...
Twitter-private-picture-ban
Twitter Continues to Ban Trump But Allows Accounts Created by Dictators and Terrorist Organizations to
Leopoldo López, one of the opposition leaders in Venezuela, recently expressed his surprise that Donald...
French Senate to Vote on Mandatory Vaccination for all Citizens Aged 24 to 59
The French Senate is set to vote on a bill that would make COVID-19 vaccinations mandatory for large...
US Submarine Collides With Unknown Object in South China Sea
On Oct. 2, the USS Connecticut struck a mysterious object while submerged in the South China Sea. It...
US Forces Secretly Training Taiwan Military as Threat From Beijing Grows
Approximately two dozen members of U.S. special-operations and support troops are engaged in training...
Beijing, Taking Over Taiwan, Would Lead to ‘Catastrophic’ Consequences Warns Taiwanese President
On Oct. 5, Taiwanese President Tsai Ing-wen wrote in an essay for Foreign Affairs that Taipei, falling...
A contact tracing QR code is seen at the entrance of a restaurant in Sydney on July 13, 2021. Rashays, a 27-location chain based in Sydney, says it will not reopen its doors when the New South Wales government relaxes restrictions on Oct. 1. Instead, Rashays will wait until Dec. 1 when vaccine passports are scheduled to be scrapped entirely. Co-founder Rami Ykmour said his company expects to lose $10 million during the delay, but feels the sacrifice is worth it for their business values.
Australian Restaurant Chain Expects to Lose $10 Million to Postpone Reopening Until ‘It’s a One-tier
A 27-location restaurant chain in Australia’s New South Wales (NSW) state will remain closed after the...
Employees of Merck Serono look from the headquarter's windows on April 24, 2012 in Geneva. Researchers from the University of North Carolina have said Merck’s new COVID-19 pill based on molnupiravir “Will be incorporated in the DNA.”
Merck’s COVID Pill ‘Will be Incorporated in the DNA’: Researcher
Merck’s newly announced pill to treat Coronavirus Disease 2019 (COVID-19) based on the molnupiravir compound...